Pulike Biological Engineering, Inc. (SHA:603566)
China · Delayed Price · Currency is CNY 11.59
-0.19 (-1.61%)
May 12, 2026, 3:00 PM CST
SHA:603566 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 172.82 | 184.99 | 92.81 | 174.52 | 167.82 | 244.14 |
Depreciation & Amortization | 122.48 | 122.48 | 120.18 | 92.73 | 74.84 | 59.46 |
Other Amortization | 0.57 | 0.57 | 2.11 | 0.53 | 0.48 | - |
Loss (Gain) From Sale of Assets | 0.63 | 0.63 | 11.35 | 0.41 | 0.21 | 0.71 |
Asset Writedown & Restructuring Costs | -7.77 | -7.77 | 1.93 | 0.23 | 0.33 | 2.63 |
Loss (Gain) From Sale of Investments | -3.79 | -3.79 | 8.31 | 0.03 | 19.93 | -20.39 |
Provision & Write-off of Bad Debts | - | - | -5.27 | 27.66 | 15.33 | 8.24 |
Other Operating Activities | -74.19 | -2.95 | 0.5 | -3.11 | 4.91 | 0.22 |
Change in Accounts Receivable | 47.17 | 47.17 | 88.95 | -6.43 | -219.23 | -102.27 |
Change in Inventory | 10.25 | 10.25 | -9.99 | 7.89 | -19.67 | -36.75 |
Change in Accounts Payable | -8.43 | -8.43 | -40.06 | -16.43 | 198.59 | 44.3 |
Change in Other Net Operating Assets | 1.37 | 1.37 | 0.93 | 5.06 | -5.95 | 9.06 |
Operating Cash Flow | 272.92 | 356.34 | 268.79 | 282.78 | 228.36 | 212.53 |
Operating Cash Flow Growth | -14.73% | 32.57% | -4.95% | 23.83% | 7.45% | -18.83% |
Capital Expenditures | -72.57 | -75.04 | -121.06 | -304.98 | -357.16 | -317.54 |
Sale of Property, Plant & Equipment | 0.15 | 0.11 | 2.22 | 0.43 | 0.45 | 1.07 |
Cash Acquisitions | -9.18 | -9.18 | - | -23.14 | - | - |
Investment in Securities | -139.84 | -146.82 | -78.78 | 299.6 | -625.75 | 177.6 |
Other Investing Activities | 14.96 | 13.36 | 9.35 | 26.43 | 27.27 | 8.36 |
Investing Cash Flow | -206.48 | -217.56 | -188.26 | -1.66 | -955.19 | -130.51 |
Short-Term Debt Issued | - | - | - | - | 37 | - |
Total Debt Issued | - | - | - | - | 37 | - |
Short-Term Debt Repaid | - | - | - | -7 | -30 | - |
Long-Term Debt Repaid | - | - | -0.88 | -0.71 | - | - |
Total Debt Repaid | - | - | -0.88 | -7.71 | -30 | - |
Net Debt Issued (Repaid) | - | - | -0.88 | -7.71 | 7 | - |
Issuance of Common Stock | - | - | - | - | 892.42 | - |
Repurchase of Common Stock | - | - | -52.7 | -7.64 | - | - |
Common Dividends Paid | -205.35 | -205.15 | -137.85 | -225 | -63.65 | -157.32 |
Other Financing Activities | -1.39 | -1.39 | -0.14 | -0.67 | -3.03 | -0.25 |
Financing Cash Flow | -206.74 | -206.54 | -191.56 | -241.03 | 832.74 | -157.57 |
Foreign Exchange Rate Adjustments | -0.23 | -0.24 | 0.01 | 0.31 | 0.34 | -0.22 |
Net Cash Flow | -140.52 | -68.01 | -111.02 | 40.4 | 106.25 | -75.76 |
Free Cash Flow | 200.36 | 281.3 | 147.73 | -22.2 | -128.8 | -105.01 |
Free Cash Flow Growth | -19.03% | 90.42% | - | - | - | - |
Free Cash Flow Margin | 18.89% | 25.81% | 14.17% | -1.77% | -10.47% | -9.56% |
Free Cash Flow Per Share | 0.58 | 0.82 | 0.43 | -0.06 | -0.40 | -0.34 |
Cash Income Tax Paid | 70.35 | 65.37 | 68.11 | 101.94 | 62.05 | 79.92 |
Levered Free Cash Flow | 67.56 | 140.03 | 95.89 | -121.29 | -190.31 | -192.46 |
Unlevered Free Cash Flow | 67.56 | 140.03 | 95.95 | -120.71 | -189.77 | -192.46 |
Change in Working Capital | 62.16 | 62.16 | 36.88 | -10.21 | -55.49 | -82.47 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.